


Oncology
2024-04-10

The NCG-hIL2 mouse model, engineered to express human Interleukin-2 (IL2), facilitates the reconstitution of human NK cells, aiding in the assessment of therapeutic antibodies' efficacy, notably in ADCC. This model enhances our understanding of NK cell development and serves as a valuable tool for studying immunotherapies, particularly in cancer treatment.
More infomation about blogs

Let us know which event you're attending and we'd be happy to connect with you.
This website will store cookies on your computer. These cookies are used to collect information about how you interact with this website and enable us to remember you. We use this information to improve and customize your browsing experience, as well as to analyze and collect relevant data and metrics about visitors on this website and other platforms. For more information about the cookies we use, please refer to our privacy policy
If you decline, your information will not be tracked when visiting this website. A cookie will be used in your browser to remember your preference settings that you have not accepted.
